Skip to main content

Table 1 Availability of anti-malarials on day of the survey by retail sector and geographical region

From: Access to artesunate-amodiaquine, quinine and other anti-malarials: policy and markets in Burundi

  Retail sector Geographical region
  Public (n = 24) % Private (n = 36) % NGO (n = 10) % Bujumbura (n = 29) % Bururi (n = 24) % Kayanza (n = 17) %a
ACT 21 87.5 12 33.3 9 90.0 15 51.7 11 45.8 16 94.1
   AS-AQa 21 87.5 12 33.3 9 90.0 15 51.7 11 45.8 16 94.1
   Other first-line ACTb - - 2 5.6 - - - - 2 8.3 - -
Quinine 23 95.8 28 77.8 9 90.0 27 93.1 22 91.7 16 94.1
   Quinine injection 17 70.8 23 63.9 9 90.0 21 72.4 16 66.7 12 70.6
   Quinine tablets 23 95.8 28 77.8 9 90.0 25 86.2 19 79.2 16 94.1
   Both quinine injection and quinine tablets 17 70.8 18 50.0 9 90.0 19 65.5 13 54.2 12 70.6
Non-policy anti-malarials 1 4.2 14 38.9 - - 9 31.0 3 12.5 3 17.6
   Amodiaquine - - 1 2.8 - - 0 0.0 1 4.2 0 0.0
   Dihydroartemisinin - - 3 8.3 - - 2 6.9 1 4.2 0 0.0
   Halofantrine 1 4.2 10 27.8 - - 7 24.1 2 8.3 2 11.8
Overall anti-malarial availability 23 95.8 28 77.8 9 90.0 27 93.1 22 91.7 16 94.1
   AS-AQ only 1 4.2 0 0.0 1 10.0 0 0.0 1 4.2 1 5.9
   Quinine only 2 8.3 13 36.1 1 10.0 7 24.1 9 37.5 0 0.0
   Non-policy antimalarials only 0 0.0 1 2.8 0 0.0 1 3.4 0 0.0 0 0.0
   AS-AQ+quinine 20 83.3 8 22.2 8 80.0 13 44.8 10 41.7 13 76.5
   AS-AQ+non-policy antimalarials 0 0.0 1 2.8 0 0.0 1 3.4 0 0.0 0 0.0
   Quinine+non-policy antimalarials 1 4.2 9 25.0 0 0.0 6 20.7 3 12.5 1 5.9
   AS-AQ+quinine+non-policy anti-malarials 0 0.0 3 8.3 0 0.0 1 3.4 2 8.3 0 0.0
  1. ACT, artemisinin combination therapy; AS-AQ artesunate-amodiaquine (loose combination)
  2. a First-line treatment for uncomplicated malaria under Burundi's national antimalarial policy
  3. b Other first-line ACT antimalarials recommended by the WHO were identified (artemether-lumefantrine and dihydroartemisinin-piperquine)